Max Robotics — Global Service Robot Directory + US Certification

About

Chris Marshall is a specialist researcher in gynecological oncology, with a particular focus on the clinical and economic implications of robotic-assisted surgery within publicly funded healthcare systems. His work has made meaningful contributions to understanding how emerging surgical technologies can be integrated into cancer care, specifically for endometrial and cervical cancers. Marshall's most influential study, "Introducing Robotic Surgery into an Endometrial Cancer Service" (2015), garnered 34 citations and remains a landmark evaluation of robotic surgery's real-world impact in a UK institution, examining 196 women across ward, theatre, and pharmacy cost dimensions. This research helped establish an evidence base for robotic surgical adoption within the NHS, where resource considerations are paramount. Building on this foundation, Marshall expanded his inquiry to examine how patient factors such as obesity influence outcomes in robotic endometrial cancer surgery (2017), and later extended his scope to cervical cancer, evaluating robotic radical hysterectomy for Stage 1b disease across 90 consecutive patients (2018). Together, these studies reflect a sustained and systematic effort to validate minimally invasive robotic surgery as both clinically effective and economically viable, providing practical guidance for institutions considering or refining similar oncological surgical services.